Products from SYNkinase
SYNkinase, headquartered in Australia, is a primary producer of research-use-only biomedical reagents, which it markets to life-science and drug-discovery researchers affiliated with universities, research institutes and industry. SYNkinase was established in 2008 by Professor Andrew Wilks and Dr. Xian Bu. The founders of the company have been involved in pharmaceutical drug discovery for three decades and have extensive scientific, company and board experience.
More information at: www.adipogen.com/synkinase
Item number: SYN-1189-M001
Keywords: | SAR020106 |
Application: | Chk1 inhibitor |
CAS | 1184843-57-9 |
MW: | 382,9 D |
Item number: SYN-1215-M001
Keywords: | GW806742X, AC1NS7PT, AGN-PC-0LQ49Y |
Application: | VEGFR2 inhibitor |
CAS | 579515-63-2 |
MW: | 573,6 D |
Item number: SYN-3006-M005
Keywords: | SAHA, MK0683, Zolinza |
Application: | HDAC inhibitor |
CAS | 149647-78-9 |
MW: | 264,3 D |
Item number: SYN-1001-M005
Keywords: | ABT737 |
Application: | Bcl-2 / Bcl-X(L) / Bcl-w inhibitor |
CAS | 852808-04-9 |
MW: | 813,4 D |
Item number: SYN-1212-M001
Keywords: | SP-2509 |
Application: | LSD1 inhibitor |
CAS | 1423715-09-6 |
MW: | 437,9 D |
Item number: SYN-1042-M001
Keywords: | ZD1839, Iressa |
Application: | EGFR inhibitor |
CAS | 184475-35-2 |
MW: | 446,9 D |
Item number: SYN-1092-M001
Keywords: | MK-0457, VX-680 |
Application: | Aurora inhibitor |
CAS | 639089-54-6 |
MW: | 464,6 D |
Item number: SYN-1221-M001
Keywords: | (S)-4-Methyl-5-((2-methyl-1,4-diazepan-1-yl)sulfonyl)isoquinoline dihydrochloride, H1152 |
Application: | Cell-permeable ROCK inhibitor |
CAS | 871543-07-6 |
MW: | 392,3 D |
Item number: SYN-1162-M001
Keywords: | MK2206 |
Application: | AKT inhibitor |
CAS | 1032350-13-2 |
MW: | 480,4 D |
Item number: SYN-1166-M100
Keywords: | AZD8055, CCG168 |
Application: | mTOR inhibitor |
CAS | 1009298-09-2 |
MW: | 465,5 D |
Item number: SYN-1024-M001
Keywords: | BMS5 |
Application: | LIMK1 / LIMK2 inhibitor |
CAS | 1338247-35-0 |
MW: | 431,3 D |
Item number: SYN-1170-M010
Keywords: | JTP-74057, GSK212, Trametinib |
Application: | MEK1 / MEK2 inhibitor |
CAS | 871700-17-3 |
MW: | 615,4 D |